luspatercept

In a much-needed positive for BMS, Celgene gains FDA review for blockbuster hopeful
Fierce Biotech
Tue, 06/4/19 - 11:02 am
Celgene
Bristol-Myers Squibb
Acceleron
luspatercept
MDS
beta thalassemia
Celgene and Acceleron Submit BLA for Luspatercept
CP Wire
Fri, 04/5/19 - 11:44 am
Celgene
Acceleron
luspatercept
myelodysplastic syndrome
beta thalassemia
Celgene and Acceleron Submit BLA for Luspatercept
Fri, 04/5/19 - 10:44 am
Celgene
Acceleron
luspatercept
Celgene scores at ASH18 with double luspatercept data
Pharmaforum
Mon, 12/3/18 - 10:00 am
Celgene
luspatercept
ASH2018
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Acceleron
luspatercept
Bluebird Bio
bb21217
Amgen
AMG 420
Celgene to launch five new products through to 2020
PM Live
Mon, 10/29/18 - 07:02 pm
Celgene
Revlimid
FDA
fedratinib
ozanimod
luspatercept
bb2121
liso-cel
Here's Why Acceleron Pharma Inc. Lost 10.2% in July
Yahoo/Motley Fool
Sun, 08/5/18 - 07:17 pm
Acceleron
clinical trials
luspatercept
A 7-year-old alliance between Celgene and Acceleron is paying off with more promising PhIII data for luspatercept
Endpoints
Mon, 07/9/18 - 06:54 pm
Celgene
Acceleron
beta thalassemia
luspatercept
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Thu, 06/28/18 - 07:10 pm
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Big News Is Fast Approaching for Celgene
Motley Fool
Fri, 06/8/18 - 11:39 pm
Celgene
luspatercept
beta thalassemia
MDS
2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Motley Fool
Sun, 04/22/18 - 11:52 am
Celgene
Bluebird Bio
beta thalassemia
LentiGlobin
luspatercept
5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade
Motley Fool
Wed, 09/27/17 - 11:22 am
Celgene
ozanimod
GED-0301
luspatercept
marizomib
CC-220
FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Lower-Risk Myelodysplastic Syndromes
Yahoo
Mon, 12/7/15 - 10:34 am
FDA
fast track
luspatercept
myelodysplastic syndromes
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Yahoo
Sun, 12/6/15 - 10:16 am
Celgene
Acceleron
myelodysplastic syndromes
MDS
luspatercept
Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters
Seeking Alpha
Wed, 07/22/15 - 10:28 am
Acceleron
luspatercept
Celgene
dalantercept
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Mon, 05/18/15 - 11:16 am
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals